Kelly T Carter

7PUBLICATIONS
45CO-AUTHORS
Predictive and prognostic markersEpigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Aug 20, 2026
Spatial multi-omics and single-cell transcriptomics uncover senescence-associated cellular programs during colon adenoma to cancer progression.

|Jun 09, 2023
Elevated EVL Methylation Level in the Normal Colon Mucosa Is a Potential Risk Biomarker for Developing Recurrent Adenomas.

Ming Yu, Kelly T Carter, Kelsey K Baker

|Jun 15, 2022
Novel DNA Methylation Biomarker Panel for Detection of Esophageal Adenocarcinoma and High-Grade Dysplasia.

Ming Yu, Helen R Moinova, Amber Willbanks

|Apr 15, 2022
Colorectal Cancer Is Associated with the Presence of Cancer Driver Mutations in Normal Colon.

Julia Matas, Brendan Kohrn, Jeanne Fredrickson

|Apr 12, 2022
Evaluation of methylated DCR1 as a biomarker for response to adjuvant irinotecan-based therapy in stage III colon cancer: cancer and leukaemia Group B 89803 (Alliance).

Lynn Symonds, Ming Yu, YuHong Zhang

|Aug 08, 2019
Senescence-associated tissue microenvironment promotes colon cancer formation through the secretory factor GDF15.

Yuna Guo, Jessica L Ayers, Kelly T Carter

Pageof 2

Frequent Collaborators

6 joint publications

William M Grady

5 joint publications

Ming Yu

2 joint publications

John M Inadomi

2 joint publications

Ting Wang